Campbell Noll L
Department of Pharmacy Practice Purdue University College of Pharmacy West Lafayette, Indiana Indiana University Center for Aging Research Regenstrief Institute Indiana University Center for Healthcare Innovation and Implementation Science Indianapolis, Indiana.
Sr Care Pharm. 2023 Jan 1;38(1):3-4. doi: 10.4140/TCP.n.2023.3.
A number of barriers to deprescribing exist, with knowledge, skills, and self-efficacy often highlighted by prescribers within an interrupted, siloed nature of the existing health care system. Thus, deprescribing is not likely to occur without a change in the system. Pharmacists are extremely well positioned to positively impact the deprescribing process, and particularly senior care pharmacists given familiarity with population-specific pharmacodynamic and pharmacokinetic characteristics of medications. Similarly, our health care partners have endorsed pharmacists to not only collaborate but to drive the deprescribing trials. Therefore, no other profession is better positioned to advocate for the value of deprescribing as a core component of the pharmaceutical care process.
存在一些减药障碍，在现有医疗保健系统间断、孤立的性质下，开药者常常强调知识、技能和自我效能。因此，如果系统不改变，减药不太可能发生。药剂师在积极影响减药过程方面具有极为有利的条件，特别是老年护理药剂师，因为他们熟悉特定人群的药物药效学和药代动力学特征。同样，我们的医疗保健合作伙伴认可药剂师不仅要进行合作，还要推动减药试验。因此，没有其他职业比药剂师更有条件倡导将减药作为药物治疗过程的核心组成部分的价值。
